Affimed $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
Option Care Health $500 million notes offering
The company issued high-yield senior notes due 2029 in the Rule 144A / Regulation S offering
IVERIC bio $173.4 million stock offering
We advised the underwriters on the SEC-registered equity offering
MicroTech Medical HK$1.82 billion IPO
We advised MicroTech Medical on its IPO and HKEX listing
Abbisko HK$1.7 billion IPO
We advised Abbisko on its IPO and HKEX listing
PHC Holdings ¥82.6 billion IPO
We advised the international managers in connection with the IPO and TSE listing
Inventiva at-the-market offering
We advised the sales agent on the SEC-registered offering of ADSs
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing